News Conference News AHA 2023 Reductions in Plaque, Inflammation Appear to Explain Statin Benefit in HIV Todd Neale November 17, 2023
Presentation AHA 2023 Physician Optimised Postpartum Hypertension Treatment (POP-HT) Randomised Trial Presenter: Jamie Kitt November 17, 2023
News Conference News AHA 2023 Novel AI-Guided CV Risk Prediction Takes Aim at Coronary Inflammation L.A. McKeown November 17, 2023
Presentation AHA 2023 The Artesia trial: Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation Presenter: Jeff Healey November 16, 2023
News Conference News AHA 2023 Sudden Cardiac Death Declining Among NCAA Athletes Michael O'Riordan November 15, 2023
Presentation AHA 2023 Validation of a Speech Analysis Application to Detect Worsening Heart Failure Events in Ambulatory Heart Failure Patients Presenter: William T. Abraham November 15, 2023
News Conference News AHA 2023 AI Improves Detection of Cardiomyopathy in Pregnancy L.A. McKeown November 15, 2023
News Conference News AHA 2023 New CVD Risk Tool Can Spur Even Earlier Talk About Prevention Yael L. Maxwell November 14, 2023
News Conference News AHA 2023 Large, Sustained Reductions in Lp(a) With Lepodisiran in Phase I Study Michael O'Riordan November 13, 2023
Presentation AHA 2023 Screening For Peripartum Cardiomyopathies Using An AI-Enhanced Digital Stethoscope: A Randomized Clinical Trial Presenter: Demilade Adedinsewo November 13, 2023
News Conference News AHA 2023 POP-HT: Physician-Guided Self-Monitoring Improves BP After Hypertensive Pregnancy L.A. McKeown November 13, 2023
News Conference News AHA 2023 New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference? Shelley Wood November 13, 2023
News Conference News AHA 2023 Gene Editing Shuts Off PCSK9 to Lower LDL in HeFH Caitlin E. Cox November 12, 2023
News Conference News AHA 2023 RNA-Interference Agent Zilebesiran Looks Promising for BP: KARDIA-1 Caitlin E. Cox November 11, 2023
Presentation AHA 2023 Safety and Pharmacodynamic Effects of VERVE-101 Presenter: Andrew Bellinger November 11, 2023
Presentation AHA 2023 Population Health and Obesity: Achieving Equity and Feasibility Presenter: Tiffany M. Powell-Wiley November 11, 2023
Presentation AHA 2023 Lepodisiran: An Extended-Duration siRNA Targeting Lipoprotein(a) Presenter: Steven E. Nissen November 11, 2023
News Conference News AHA 2023 Inflammation More Powerful Than LDL as CV Risk Predictor in Statin-Free Patients Caitlin E. Cox November 07, 2023